Prospective multi-center study of the impact of Oncotype® DX Colon Cancer Assay results on treatment recommendations in stage II colon cancer patients

被引:0
|
作者
Srivastava, G. [1 ]
Renfro, L. A. [1 ]
Behrens, R. J. [2 ]
Lopatin, M. [3 ]
Chao, C. [3 ]
Soori, G. S. [4 ]
Dakhil, S. R. [5 ]
Kim, G. [6 ]
Lee, M. [3 ]
Alberts, S. R. [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
[2] Med Oncol & Hematol Associates, Oncol, Des Moines, IA USA
[3] Genom Hlth Inc, Red Wood City, CA USA
[4] Alegent Bergen Mercy Canc Ctr, Omaha, NE USA
[5] Canc Ctr Kansas, Wichita, KS USA
[6] Mayo Clin, Jacksonville, FL 32224 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2184
引用
收藏
页码:S493 / S493
页数:1
相关论文
共 50 条
  • [1] Prospective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer Patients
    Srivastava, Geetika
    Renfro, Lindsay A.
    Behrens, Robert J.
    Lopatin, Margarita
    Chao, Calvin
    Soori, Gamini S.
    Dakhil, Shaker R.
    Mowat, Rex B.
    Kuebler, J. Philip
    Kim, George
    Mazurczak, Miroslaw
    Lee, Mark
    Alberts, Steven R.
    ONCOLOGIST, 2014, 19 (05): : 492 - 497
  • [2] Effect of Oncotype DX colon cancer test results on treatment recommendations in patients with stage II colon cancer: Preliminary results.
    Cartwright, Thomas H.
    Chao, Calvin
    Lopatin, Margarita
    Bentley, Tanya G. K.
    Broder, Michael Samuel
    Chang, Eunice
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Oncotype DX® colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence
    You, Y. Nancy
    Rustin, Rudolph B.
    Sullivan, James D.
    SURGICAL ONCOLOGY-OXFORD, 2015, 24 (02): : 61 - 66
  • [4] Effect of the 12-gene colon cancer assay results on treatment recommendations in patients with stage II colon cancer
    Cartwright, Thomas H.
    Chao, Calvin
    Lopatin, Margarita
    Bentley, Tanya G.
    Broder, Michael S.
    Chang, Eunice
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Effect of the 12-gene colon cancer assay results on adjuvant treatment recommendations in patients with stage II colon cancer
    Cartwright, T.
    Chao, C.
    Lee, M.
    Lopatin, M.
    Bentley, T.
    Broder, M.
    Chang, E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (02) : 321 - 328
  • [6] Prospective evaluation of a 12-gene assay on treatment recommendations in patients with stage II colon cancer
    Srivastava, Geetika
    Renfro, Lindsay Anne
    Behrens, Robert J.
    Lopatin, Margarita
    Chao, Calvin
    Soori, Gamini S.
    Dakhil, Shaker R.
    Mowat, Rex Bradford
    Kuebler, J. Phillip
    Kim, George P.
    Mazurczak, Miroslaw
    Lee, Mark
    Alberts, Steven R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [7] Application of Microsatellite Instability and Oncotype DX in Stage II Colon Cancer Adjuvant Chemotherapy
    Chu, Edward
    CURRENT COLORECTAL CANCER REPORTS, 2011, 7 (04) : 260 - 266
  • [8] Prognostic factors for patients with stage II colon cancer: results of a prospective study
    Chenghai Zhang
    Jiabo Di
    Beihai Jiang
    Ming Cui
    Zaozao Wang
    Jiadi Xing
    Hong Yang
    Zhendan Yao
    Nan Zhang
    Xiangqian Su
    International Journal of Colorectal Disease, 2016, 31 : 123 - 129
  • [9] Prognostic factors for patients with stage II colon cancer: results of a prospective study
    Zhang, Chenghai
    Di, Jiabo
    Jiang, Beihai
    Cui, Ming
    Wang, Zaozao
    Xing, Jiadi
    Yang, Hong
    Yao, Zhendan
    Zhang, Nan
    Su, Xiangqian
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2016, 31 (01) : 123 - 129
  • [10] Results of the Turkish prospective multi-center study utilizing the 21-gene Oncotype DX assay: Decision impact analysis.
    Ozmen, Vahit
    Atasoy, Ajlan
    Gokmen, Erhan
    Ozdogan, Mustafa
    Guler, Emine Nilufer
    Uras, Cihan
    Ok, Engin
    Demircan, Orhan
    Isikdogan, Abdurrahman
    Pilanci, Kezban Nur
    Ordu, Cetin
    Duman, Oben
    Ates, Ozturk
    Sen, Fatma
    Kara, Halil
    Oz, Bahadir
    Saip, Pinar
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)